PlainRecalls
FDA Drug Moderate Class II Terminated

Propofol Injectable Emulsion, 1%, (10mg/mL), packaged in a) 200 mg/20 mL, 5 Units x 20 mL Single patient infusion vials per carton (NDC 0409-4699-30); b) 1 g/100 mL, 10 Units x 100 mL Single patient infusion vials per carton (NDC 0409-4699-24); Rx only, Hospira, Inc., Lake Forest, IL 60045, USA.

Reported: June 20, 2012 Initiated: April 11, 2012 #D-1382-2012

Product Description

Propofol Injectable Emulsion, 1%, (10mg/mL), packaged in a) 200 mg/20 mL, 5 Units x 20 mL Single patient infusion vials per carton (NDC 0409-4699-30); b) 1 g/100 mL, 10 Units x 100 mL Single patient infusion vials per carton (NDC 0409-4699-24); Rx only, Hospira, Inc., Lake Forest, IL 60045, USA.

Reason for Recall

Presence of Particulate Matter: A single visible particulate was observed in a retention sample bottles identified as stainless steel

Details

Recalling Firm
Hospira, Inc.
Units Affected
a) 36,125 vials; b) 31,280 vials
Distribution
Nationwide.
Location
Lake Forest, IL

Frequently Asked Questions

What product was recalled?
Propofol Injectable Emulsion, 1%, (10mg/mL), packaged in a) 200 mg/20 mL, 5 Units x 20 mL Single patient infusion vials per carton (NDC 0409-4699-30); b) 1 g/100 mL, 10 Units x 100 mL Single patient infusion vials per carton (NDC 0409-4699-24); Rx only, Hospira, Inc., Lake Forest, IL 60045, USA.. Recalled by Hospira, Inc.. Units affected: a) 36,125 vials; b) 31,280 vials.
Why was this product recalled?
Presence of Particulate Matter: A single visible particulate was observed in a retention sample bottles identified as stainless steel
Which agency issued this recall?
This recall was issued by the FDA Drug on June 20, 2012. Severity: Moderate. Recall number: D-1382-2012.